MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
Galectin Therapeutics, Inc. (NASDAQ: GALT)*
*Key People: Galectin
Parents
Galectin Therapeutics, Inc. (NASDAQ: GALT)*
Children
Galectin CEO Joel Lewis (2024)
Galectin Chief Medical Officer Khurram Jamil, M.D_2024
Number of employees: 9 (2022)
Jumps
Finance & Acquisitions: Galectin
Organization & Developments: Galectin